載入...
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene decrease the structural stability and function of the CFTR protein, resulting in cystic fibrosis. Recently, the effect of CFTR-targeting combination therapy has dramatically increased, and it is expected that add-on dru...
Na minha lista:
| 發表在: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243099/ https://ncbi.nlm.nih.gov/pubmed/32331485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13040075 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|